Literature DB >> 171657

Enhanced representation of HL-A antigens on human lymphocytes after mitogenesis induced by phytohemagglutinin or Epstein-Barr virus.

J M McCune, R E Humphreys, R R Yocum, J L Strominger.   

Abstract

The amount of HL-A antigens present on the peripheral blood lymphocytes of a single human donor was increased about 11-fold after stimulation with phytohemagglutinin and 36-fold after transformation with Epstein-Barr virus. This increase applied to all four HL-A specificities of these cells. The response to phytohemagglutinin was dependent on dose and was first observed at 12 hr of incubation. Measurements of the amount of surface membranes by geometry, by radioiodinatable surface proteins, and by 5'-nucleotidase (5'-ribonucleotide phosphohydrolase, EC 3.1.3.5) assay all indicated that the enhanced representation of HL-A antigens after stimulation by phytohemagglutinin or transformation by Epstein-Barr virus must be due to an increase in the density of these antigens on the cell surface.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 171657      PMCID： PMC432951          DOI： 10.1073/pnas.72.8.3206

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


  19 in total

1.  Interaction of plant lectins with purified human lymphocyte populations: binding characteristics and kinetics of proliferation.

Authors:  D H Boldt; R P MacDermott; E P Jorolan
Journal:  J Immunol       Date:  1975-05       Impact factor: 5.422

2.  HL-A typing of cultured peripheral lymphoblastoid cells.

Authors:  H M Dick; C M Steel; W B Crichton
Journal:  Tissue Antigens       Date:  1972

Review 3.  The immunoglobulin-like structure of human histocompatibility antigens.

Authors:  J L Strominger; P Cresswell; H Grey; R E Humphreys; D Mann; P Parham; R Robb; A R Sanderson; T A Springer; C Terhorst; M J Turner
Journal:  Transplant Rev       Date:  1974

4.  The interaction of normal lymphocytes and cells from lymphoid cell lines. IV. HL-A typing of the cell line cells.

Authors:  P Mackintosh; J Wallin; D A Hardy; N R Ling; C M Steel
Journal:  Immunology       Date:  1973-02       Impact factor: 7.397

5.  Expression of HL-A antigens in synchronized cultures of human lymphocytes.

Authors:  M A Pellegrino; S Ferrone; P G Natali; A Pellegrino; R A Reisfeld
Journal:  J Immunol       Date:  1972-02       Impact factor: 5.422

6.  Extraneous lymphocytic HL-A antigens in severe combined immunodeficiency disease.

Authors:  P I Terasaki; T Miyajima; D P Sengar; E R Stiehm
Journal:  Transplantation       Date:  1972-03       Impact factor: 4.939

7.  HL-A typing of "leukaemic" cells.

Authors:  G D Pegrum; I C Balfour; C A Evans; V L Middleton
Journal:  Lancet       Date:  1971-04-24       Impact factor: 79.321

8.  HL-A antigens of human lymphoid cells in long-term tissue culture.

Authors:  G N Rogentine; P Gerber
Journal:  Transplantation       Date:  1969-07       Impact factor: 4.939

9.  Isolation and characterization of HL-A variants in cultured human lymphoid cells.

Authors:  D Pious; P Hawley; G Forrest
Journal:  Proc Natl Acad Sci U S A       Date:  1973-05       Impact factor: 11.205

10.  Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.

Authors:  G Miller; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-01       Impact factor: 11.205
View more
  18 in total

1.  The binding of monoclonal antibodies to cell-surface molecules. A quantitative analysis with immunoglobulin G against two alloantigenic determinants of the human transplantation antigen HLA-A2.

Authors:  J P Ways; P Parham
Journal:  Biochem J       Date:  1983-11-15       Impact factor: 3.857

2.  Recognition of HLA-A2 and -B7 antigens by cloned cytotoxic T lymphocytes after gene transfer into human and monkey, but not mouse, cells.

Authors:  J A Barbosa; S J Mentzer; G Minowada; J L Strominger; S J Burakoff; P A Biro
Journal:  Proc Natl Acad Sci U S A       Date:  1984-12       Impact factor: 11.205

3.  Dissociation and exchange of the beta 2-microglobulin subunit of HLA-A and HLA-B antigens.

Authors:  F Hyafil; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

4.  Phosphorylation in vivo and in vitro of human histocompatibility antigens (HLA-A and HLA-B) in the carboxy-terminal intracellular domain.

Authors:  J S Pober; B C Guild; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1978-12       Impact factor: 11.205

5.  Serological analysis of xenogeneic anti-lymphoblastoid cell-line sera with specificity against HLA-B12.

Authors:  K Schäfer; E D Albert; H Rodt; S Thierfelder
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

6.  High-level expression of a cloned HLA heavy chain gene introduced into mouse cells on a bovine papillomavirus vector.

Authors:  D DiMaio; V Corbin; E Sibley; T Maniatis
Journal:  Mol Cell Biol       Date:  1984-02       Impact factor: 4.272

7.  Isolation and immunologic characterization of a human. B-lymphocyte-specific, cell surface antigen.

Authors:  R E Humphreys; J M McCune; L Chess; H C Herrman; D J Malenka; D L Mann; P Parham; S F Schlossman; J L Strominger
Journal:  J Exp Med       Date:  1976-07-01       Impact factor: 14.307

8.  Alloantigens expressed on activated human T cells different from HLA-A, B, C, and DR antigens.

Authors:  M Gerbase de Lima; E E Wollman; V Lepage; L Degos; J Dausset
Journal:  Immunogenetics       Date:  1981       Impact factor: 2.846

9.  Herpes simplex virus infection of human fibroblasts and keratinocytes inhibits recognition by cloned CD8+ cytotoxic T lymphocytes.

Authors:  D M Koelle; M A Tigges; R L Burke; F W Symington; S R Riddell; H Abbo; L Corey
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

10.  Human (HLA-A and HLA-B) and murine (H-2K and H-2D) histocompatibility antigens are cell surface receptors for Semliki Forest virus.

Authors:  A Helenius; B Morein; E Fries; K Simons; P Robinson; V Schirrmacher; C Terhorst; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.